Glutsch, Valerie
Kneitz, Hermann
Gesierich, Anja
Goebeler, Matthias
Haferkamp, Sebastian
Becker, Jürgen C.
Ugurel, Selma
Schilling, Bastian http://orcid.org/0000-0001-8859-4103
Funding for this research was provided by:
Projekt DEAL
Article History
Received: 28 September 2020
Accepted: 14 December 2020
First Online: 13 January 2021
Compliance with ethical standards
:
: <i>Valerie Glutsch</i> has received honoraria from Bristol-Myers Squibb (BMS) and reports travel support from Novartis, Pierre Fabre Pharmaceuticals, BMS, Merck Sharp and Dohme (MSD) and Sanofi Genzyme; outside the submitted work. <i>Anja Gesierich</i> reports advisory roles for BMS, MSD Sharp and Dohme, Novartis, Roche, Pierre Fabre Pharmaceuticals, Pfizer and Sanofi Genzyme, has received honoraria from BMS, MSD Sharp and Dohme, Novartis and Roche, and travel support from BMS, MSD Sharp and Dohme, Novartis, Roche and Pierre Fabre Pharmaceuticals; outside of the submitted work. <i>Sebastian Haferkamp</i> is on the advisory board or has received honoraria and travel support from Amgen, Bristol-Myers Squibb, Merck Sharp and Dohme, Novartis, Pierre Fabre, Roche, and Sanofi; outside the submitted work. <i>Selma Ugurel</i> declares research support from Bristol-Myers Squibb and Merck Serono; speakers and advisory board honoraria from Bristol-Myers Squibb, Merck Sharp and Dohme, Merck Serono, Novartis and Roche, and travel support from Bristol-Myers Squibb, and Merck Sharp and Dohme. <i>Jürgen C. Becker</i> has received speaker’s bureau honoraria from Amgen, Pfizer, MerckSerono, Recordati and Sanofi, is a paid consultant/advisory board member/DSMB member for Boehringer Ingelheim, eTheRNA, InProTher, MerckSerono, Pfizer, 4SC, and Sanofi/Regeneron. His group receives research grants from Bristol-Myers Squibb, Merck Serono, HTG, IQVIA, and Alcedis. <i>Bastian Schilling</i> has received personal honoraria from Bristol-Myers Squibb, Merck Sharpe and Dome, Novartis, Pfizer/EMD Serono, Pierre Fabre and Roche; has an advisory role for Bristol-Myers Squibb, Merck Sharpe and Dome, Novartis, Pierre Fabre and Roche; and has received research funding from Bristol-Myers Squibb, Merck Sharpe and Dome, and Pierre Fabre, all paid to the institute. The other authors declare no potential conflicts of interest.
: Due to the retrospective nature of the study and the collection of anonymous patient data, informed consent was waived by the Ethics Committee of the University Hospital Würzburg.
: Not applicable.
: Publication of patient photos was approved by written consent.